Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cawachi Ltd. (2664:JPX), powered by AI.
Cawachi Ltd. is currently trading at ¥3,520. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cawachi Ltd. on Alpha Lenz.
Cawachi Ltd.'s P/E ratio is 16.1.
“Cawachi Ltd. trades at a P/E of 16.1 (fair value) with modest ROE of 4.3%.”
Ask for details →Cawachi Ltd. operates as a prominent entity in the Japanese retail pharmacy industry. The company's primary function revolves around the operation of drugstore chains that serve local communities with pharmaceutical products and health-related services. Notable for its comprehensive range of offerings, Cawachi Ltd. provides customers with prescription medications, over-the-counter drugs, and an assortment of daily necessities. These include healthcare supplies, beauty products, and household essentials. Cawachi Ltd. maintains a significant presence in Japan, with a network of stores strategically located to optimize accessibility and customer reach. Its role in the market is crucial, as it ensures the availability of health-related goods and services, contributing to the wellbeing and convenience of consumers. By adapting to consumer trends and expanding its service offerings, Cawachi Ltd. plays an essential part in the retail pharmacy sector, balancing traditional brick-and-mortar retail with the evolving online shopping landscape.
“Cawachi Ltd. trades at a P/E of 16.1 (fair value) with modest ROE of 4.3%.”
Ask for details →Cawachi Ltd. (ticker: 2664) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 2,733 employees. Market cap is $78.6B.
The current price is 3,520 with a P/E ratio of 16.09x and P/B of 0.69x.
ROE is 4.33% and operating margin is 2.59%. Annual revenue is $287.8B.